{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:58:27Z","timestamp":1791089907998,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,9]],"date-time":"2012-07-09T00:00:00Z","timestamp":1341792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,7,9]],"date-time":"2012-07-09T00:00:00Z","timestamp":1341792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/bmt.2012.132","type":"journal-article","created":{"date-parts":[[2012,7,9]],"date-time":"2012-07-09T07:36:17Z","timestamp":1341819377000},"page":"269-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients"],"prefix":"10.1038","volume":"48","author":[{"given":"M","family":"Foglietta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S S","family":"Neelapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L W","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nattamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-T","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Sportes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Gress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Vence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Radvanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Qazilbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R N K","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,9]]},"reference":[{"key":"BFbmt2012132_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/35077251","volume":"411","author":"FR Appelbaum","year":"2001","unstructured":"Appelbaum FR . Haematopoietic cell transplantation as immunotherapy. Nature 2001; 411: 385\u2013389.","journal-title":"Nature"},{"key":"BFbmt2012132_CR2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813\u20131826.","journal-title":"N Engl J Med"},{"key":"BFbmt2012132_CR3","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1182\/blood-2011-03-339945","volume":"117","author":"L Giaccone","year":"2011","unstructured":"Giaccone L, Storer B, Patriarca F, Rotta M, Sorasio R, Allione B et al. Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma. Blood 2011; 117: 6721\u20136727.","journal-title":"Blood"},{"key":"BFbmt2012132_CR4","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1182\/blood-2006-07-036848","volume":"109","author":"C Crawley","year":"2007","unstructured":"Crawley C, Iacobelli S, Bjorkstrand B, Apperley JF, Niederwieser D, Gahrton G . Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning. Blood 2007; 109: 3588\u20133594.","journal-title":"Blood"},{"key":"BFbmt2012132_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1073\/pnas.69.6.1540","volume":"69","author":"RG Lynch","year":"1972","unstructured":"Lynch RG, Graff RJ, Sirisinha S, Simms ES, Eisen HN . Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci USA 1972; 69: 1540\u20131544.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt2012132_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/254714a0","volume":"254","author":"GT Stevenson","year":"1975","unstructured":"Stevenson GT, Stevenson FK . Antibody to a molecularly-defined antigen confined to a tumour cell surface. Nature 1975; 254: 714\u2013716.","journal-title":"Nature"},{"key":"BFbmt2012132_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/13928","volume":"5","author":"M Bendandi","year":"1999","unstructured":"Bendandi M, Gocke CD, Kobrin CB, Benko FA, Sternas LA, Pennington R et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999; 5: 1171\u20131177.","journal-title":"Nat Med"},{"key":"BFbmt2012132_CR8","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nm1290","volume":"11","author":"SS Neelapu","year":"2005","unstructured":"Neelapu SS, Kwak LW, Kobrin CB, Reynolds CW, Janik JE, Dunleavy K et al. Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma. Nat Med 2005; 11: 986\u2013991.","journal-title":"Nat Med"},{"key":"BFbmt2012132_CR9","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1200\/JCO.2010.33.3005","volume":"29","author":"SJ Schuster","year":"2011","unstructured":"Schuster SJ, Neelapu SS, Gause BL, Janik JE, Muggia FM, Gockerman JP et al. Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol 2011; 29: 2787\u20132794.","journal-title":"J Clin Oncol"},{"key":"BFbmt2012132_CR10","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V93.7.2411","volume":"93","author":"VL Reichardt","year":"1999","unstructured":"Reichardt VL, Okada CY, Liso A, Benike CJ, Stockerl-Goldstein KE, Engleman EG et al. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study. Blood 1999; 93: 2411\u20132419.","journal-title":"Blood"},{"key":"BFbmt2012132_CR11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood.V94.2.673","volume":"94","author":"M Massaia","year":"1999","unstructured":"Massaia M, Borrione P, Battaglio S, Mariani S, Beggiato E, Napoli P et al. Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. Blood 1999; 94: 673\u2013683.","journal-title":"Blood"},{"key":"BFbmt2012132_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/10428190500272473","volume":"47","author":"M Bendandi","year":"2006","unstructured":"Bendandi M, Rodriguez-Calvillo M, Inoges S, Lopez-Diaz de Cerio A, Perez-Simon JA, Rodriguez-Caballero A et al. Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation. Leuk Lymphoma 2006; 47: 29\u201337.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2012132_CR13","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood.V87.7.3053.bloodjournal8773053","volume":"87","author":"LW Kwak","year":"1996","unstructured":"Kwak LW, Pennington R, Longo DL . Active immunization of murine allogeneic bone marrow transplant donors with B-cell tumor-derived idiotype: a strategy for enhancing the specific antitumor effect of marrow grafts. Blood 1996; 87: 3053\u20133060.","journal-title":"Blood"},{"key":"BFbmt2012132_CR14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/jnci\/87.17.1289","volume":"87","author":"RL Hornung","year":"1995","unstructured":"Hornung RL, Longo DL, Bowersox OC, Kwak LW . Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor. J Natl Cancer Inst 1995; 87: 1289\u20131296.","journal-title":"J Natl Cancer Inst"},{"key":"BFbmt2012132_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(95)90757-2","volume":"345","author":"LW Kwak","year":"1995","unstructured":"Kwak LW, Taub DD, Duffey PL, Bensinger WI, Bryant EM, Reynolds CW et al. Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet 1995; 345: 1016\u20131020.","journal-title":"Lancet"},{"key":"BFbmt2012132_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/sj.bmt.1705057","volume":"36","author":"SS Neelapu","year":"2005","unstructured":"Neelapu SS, Munshi NC, Jagannath S, Watson TM, Pennington R, Reynolds C et al. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma. Bone Marrow Transplant 2005; 36: 315\u2013323.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012132_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/sj.bmt.1702399","volume":"25","author":"R Cabrera","year":"2000","unstructured":"Cabrera R, Diaz-Espada F, Barrios Y, Briz M, Fores R, Barbolla L et al. Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma. Bone Marrow Transplant 2000; 25: 1105\u20131108.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012132_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/j.seminoncol.2003.11.001","volume":"31","author":"LW Kwak","year":"2004","unstructured":"Kwak LW, Neelapu SS, Bishop MR . Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion. Semin Oncol 2004; 31: 37\u201346.","journal-title":"Semin Oncol"},{"key":"BFbmt2012132_CR19","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood.V88.7.2775.bloodjournal8872775","volume":"88","author":"HD Ottinger","year":"1996","unstructured":"Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H . Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775\u20132779.","journal-title":"Blood"},{"key":"BFbmt2012132_CR20","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1182\/blood.V89.10.3891","volume":"89","author":"J Storek","year":"1997","unstructured":"Storek J, Witherspoon RP, Maloney DG, Chauncey TR, Storb R . Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. Blood 1997; 89: 3891\u20133893.","journal-title":"Blood"},{"key":"BFbmt2012132_CR21","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","volume":"97","author":"J Storek","year":"2001","unstructured":"Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380\u20133389.","journal-title":"Blood"},{"key":"BFbmt2012132_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/bmt.2010.173","volume":"46","author":"S Jamshed","year":"2011","unstructured":"Jamshed S, Fowler DH, Neelapu SS, Dean RM, Steinberg SM, Odom J et al. EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant 2011; 46: 676\u2013681.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012132_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blade","year":"1998","unstructured":"Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998; 102: 1115\u20131123.","journal-title":"Br J Haematol"},{"key":"BFbmt2012132_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/0008-5472.CAN-08-2361","volume":"69","author":"G Wieczorek","year":"2009","unstructured":"Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009; 69: 599\u2013608.","journal-title":"Cancer Res"},{"key":"BFbmt2012132_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(86)92315-9","volume":"1","author":"JZ Wimperis","year":"1986","unstructured":"Wimperis JZ, Brenner MK, Prentice HG, Reittie JE, Karayiannis P, Griffiths PD et al. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet 1986; 1: 339\u2013343.","journal-title":"Lancet"},{"key":"BFbmt2012132_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF00915378","volume":"6","author":"LG Lum","year":"1986","unstructured":"Lum LG, Seigneuret MC, Storb R . The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients. J Clin Immunol 1986; 6: 389\u2013396.","journal-title":"J Clin Immunol"},{"key":"BFbmt2012132_CR27","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1182\/blood.V87.7.3012.bloodjournal8773012","volume":"87","author":"DC Molrine","year":"1996","unstructured":"Molrine DC, Guinan EC, Antin JH, Parsons SK, Weinstein HJ, Wheeler C et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012\u20133018.","journal-title":"Blood"},{"key":"BFbmt2012132_CR28","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1182\/blood-2002-03-0832","volume":"101","author":"DC Molrine","year":"2003","unstructured":"Molrine DC, Antin JH, Guinan EC, Soiffer RJ, MacDonald K, Malley R et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101: 831\u2013836.","journal-title":"Blood"},{"key":"BFbmt2012132_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/sj.bmt.1704336","volume":"33","author":"J Storek","year":"2004","unstructured":"Storek J, Dawson MA, Lim LC, Burman BE, Stevens-Ayers T, Viganego F et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 2004; 33: 337\u2013346.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012132_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.bmt.1705562","volume":"39","author":"T Parkkali","year":"2007","unstructured":"Parkkali T, Kayhty H, Hovi T, Olander RM, Roivainen M, Volin L et al. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. Bone Marrow Transplant 2007; 39: 179\u2013188.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012132_CR31","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood.V87.6.2594.bloodjournal8762594","volume":"87","author":"KG Lucas","year":"1996","unstructured":"Lucas KG, Small TN, Heller G, Dupont B, O\u2032Reilly RJ . The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood 1996; 87: 2594\u20132603.","journal-title":"Blood"},{"key":"BFbmt2012132_CR32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V75.3.806.bloodjournal753806","volume":"75","author":"S Kato","year":"1990","unstructured":"Kato S, Yabe H, Yabe M, Kimura M, Ito M, Tsuchida F et al. Studies on transfer of varicella-zoster-virus specific T-cell immunity from bone marrow donor to recipient. Blood 1990; 75: 806\u2013809.","journal-title":"Blood"},{"key":"BFbmt2012132_CR33","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","volume":"114","author":"AM Leen","year":"2009","unstructured":"Leen AM, Christin A, Myers GD, Liu H, Cruz CR, Hanley PJ et al. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 2009; 114: 4283\u20134292.","journal-title":"Blood"},{"key":"BFbmt2012132_CR34","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3324\/haematol.2010.022947","volume":"95","author":"ML Zandvliet","year":"2010","unstructured":"Zandvliet ML, Falkenburg JH, van Liempt E, Veltrop-Duits LA, Lankester AC, Kalpoe JS et al. Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection. Haematologica 2010; 95: 1943\u20131951.","journal-title":"Haematologica"},{"key":"BFbmt2012132_CR35","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1158\/0008-5472.CAN-05-4233","volume":"66","author":"C Bertinetti","year":"2006","unstructured":"Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF et al. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression. Cancer Res 2006; 66: 4496\u20134502.","journal-title":"Cancer Res"},{"key":"BFbmt2012132_CR36","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/jnci\/djj358","volume":"98","author":"S Inoges","year":"2006","unstructured":"Inoges S, Rodriguez-Calvillo M, Zabalegui N, Lopez-Diaz de Cerio A, Villanueva H, Soria E et al. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma. J Natl Cancer Inst 2006; 98: 1292\u20131301.","journal-title":"J Natl Cancer Inst"},{"key":"BFbmt2012132_CR37","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1182\/blood-2010-06-292342","volume":"117","author":"MA Navarrete","year":"2011","unstructured":"Navarrete MA, Heining-Mikesch K, Schuler F, Bertinetti-Lapatki C, Ihorst G, Keppler-Hafkemeyer A et al. Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma. Blood 2011; 117: 1483\u20131491.","journal-title":"Blood"},{"key":"BFbmt2012132_CR38","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","volume":"112","author":"AS De Groot","year":"2008","unstructured":"De Groot AS, Moise L, McMurry JA, Wambre E, Van Overtvelt L, Moingeon P et al. Activation of natural regulatory T cells by IgG Fc-derived peptide \u2018Tregitopes\u2019. Blood 2008; 112: 3303\u20133311.","journal-title":"Blood"},{"key":"BFbmt2012132_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00262-010-0918-x","volume":"60","author":"M Warncke","year":"2011","unstructured":"Warncke M, Buchner M, Thaller G, Dodero A, Bulashevska A, Pfeifer D et al. Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells. Cancer Immunol Immunothe 2011; 60: 49\u201360.","journal-title":"Cancer Immunol Immunothe"},{"key":"BFbmt2012132_CR40","first-page":"162","volume":"61","author":"T Teshima","year":"2001","unstructured":"Teshima T, Mach N, Hill GR, Pan L, Gillessen S, Dranoff G et al. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Res 2001; 61: 162\u2013171.","journal-title":"Cancer Res"},{"key":"BFbmt2012132_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1084\/jem.20050732","volume":"202","author":"L Gattinoni","year":"2005","unstructured":"Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med 2005; 202: 907\u2013912.","journal-title":"J Exp Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012132","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:03:42Z","timestamp":1648033422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,9]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFbmt2012132"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.132","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,9]]},"assertion":[{"value":"5 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}